Twilight Litaka Pharma Profile
Key Indicators
- Authorised Capital ₹ 21.50 Cr
- Paid Up Capital ₹ 12.39 Cr
- Company Age 51 Year, 1 Month
- Last Filing with ROC 30 Jun 2013
- Open Charges ₹ 454.90 Cr
- Satisfied Charges ₹ 125.18 Cr
About Twilight Litaka Pharma
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24231MH1974PTC017139
- Company No.
017139
- Incorporation Date
18 Jan 1974
- Date of AGM
30 Dec 2013
- Date of Balance Sheet
30 Jun 2013
- Listing Status
Listed
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Twilight Litaka Pharma?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gopal Ramourti ![]() | Managing Director | 30-Jun-2005 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nainish Bora ![]() | Whole-Time Director | 25-Mar-2005 | Current |
Raghavan Ayyangar ![]() | Director | 31-Dec-2005 | Current |
Avinash Chandvankar ![]() | Director | 20-Apr-2002 | Current |
Financial Performance of Twilight Litaka Pharma.
Enhance accessibility to Twilight Litaka Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Twilight Litaka Pharma?
Unlock access to Twilight Litaka Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹454.90 Cr
₹125.18 Cr
Charges Breakdown by Lending Institutions
- Central Bank Of India - Security Trustee : 202.00 Cr
- Icici Bank Ltd - Consortium Member Bank : 86.31 Cr
- Icici Bank Limited : 68.50 Cr
- State Bank Of Hyderabad : 40.00 Cr
- Idbi Bank Limited : 30.00 Cr
- Others : 28.09 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Jun 2012 | Srei Infrastructure Finance Limited | ₹5.00 Cr | Open |
03 Jun 2011 | Idbi Bank Limited | ₹30.00 Cr | Open |
23 Feb 2011 | State Bank Of Hyderabad | ₹40.00 Cr | Open |
30 Jul 2009 | Central Bank Of India - Security Trustee | ₹202.00 Cr | Open |
18 Mar 2009 | Central Bank Of India | ₹5.00 M | Open |
How Many Employees Work at Twilight Litaka Pharma?
Twilight Litaka Pharma has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Twilight Litaka Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Twilight Litaka Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.